- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I clinical trial combining imatinib mesylate and IL-2
Authors
Keywords
-
Journal
OncoImmunology
Volume 2, Issue 2, Pages e23080
Publisher
Informa UK Limited
Online
2013-01-24
DOI
10.4161/onci.23080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Critical Role of IL-15 in the Antitumor Effects Mediated by the Combination Therapy Imatinib and IL-2
- (2014) G. Mignot et al. JOURNAL OF IMMUNOLOGY
- Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL- Tumors
- (2014) N. Larmonier et al. JOURNAL OF IMMUNOLOGY
- Trans-Presentation of IL-15 Dictates IFN-Producing Killer Dendritic Cells Effector Functions
- (2014) E. Ullrich et al. JOURNAL OF IMMUNOLOGY
- Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV
- (2012) Yves Lévy et al. AIDS
- Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation
- (2012) F. Guimont-Desrochers et al. BLOOD
- Exploiting antitumor immunity to overcome relapse and improve remission duration
- (2011) Lei L. Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG
- (2011) J. Henry Evans et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients
- (2010) S. Viaud et al. CANCER RESEARCH
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Meta-Analysis of 1,640 Patients
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Natural Killer Cell IFN- Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
- (2009) C. Menard et al. CANCER RESEARCH
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth
- (2009) Robbert G. van der Most et al. PLoS One
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search